Loading...
The Cooper Companies, Inc.
COO•NASDAQ
Healthcare
Medical - Instruments & Supplies
$74.59
$0.79(1.07%)
The Cooper Companies, Inc. (COO) Financial Performance & Income Statement Overview
Review The Cooper Companies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.41%
↑ 8.41%
Operating Income Growth
32.38%
↑ 32.38%
Net Income Growth
33.34%
↑ 33.34%
Operating Cash Flow Growth
16.76%
↑ 16.76%
Operating Margin
19.00%
↑ 19.00%
Gross Margin
63.43%
↑ 63.43%
Net Profit Margin
10.39%
↑ 10.39%
ROE
5.11%
↑ 5.11%
ROIC
6.65%
↑ 6.65%
The Cooper Companies, Inc. (COO) Income Statement & Financial Overview
Review The Cooper Companies, Inc.'s (COO) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $964.70M | $1.02B | $1.003B | $942.60M |
| Cost of Revenue | $304.50M | $340.70M | $390.20M | $361.70M |
| Gross Profit | $660.20M | $677.70M | $612.60M | $580.90M |
| Gross Profit Ratio | $0.68 | $0.67 | $0.61 | $0.62 |
| R&D Expenses | $40.70M | $37.70M | $39.00M | $38.90M |
| SG&A Expenses | $387.90M | $391.40M | $381.10M | $380.30M |
| Operating Expenses | $478.20M | $479.30M | $420.10M | $419.20M |
| Total Costs & Expenses | $733.10M | $820.00M | $810.30M | $780.90M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $26.00M | $27.00M | $28.50M | $28.90M |
| Depreciation & Amortization | $2.70M | $0.00 | $89.00M | $98.30M |
| EBITDA | $182.00M | $198.40M | $281.20M | $270.80M |
| EBITDA Ratio | $0.19 | $0.19 | $0.28 | $0.29 |
| Operating Income | $182.00M | $198.40M | $192.50M | $161.70M |
| Operating Income Ratio | $0.19 | $0.19 | $0.19 | $0.17 |
| Other Income/Expenses (Net) | -$28.70M | -$29.80M | -$28.80M | -$31.70M |
| Income Before Tax | $153.30M | $168.60M | $163.70M | $130.00M |
| Income Before Tax Ratio | $0.16 | $0.17 | $0.16 | $0.14 |
| Income Tax Expense | $49.00M | $51.10M | $59.00M | $41.10M |
| Net Income | $104.30M | $117.50M | $104.70M | $88.90M |
| Net Income Ratio | $0.11 | $0.12 | $0.10 | $0.09 |
| EPS | $0.52 | $0.58 | $0.53 | $0.45 |
| Diluted EPS | $0.52 | $0.58 | $0.52 | $0.44 |
| Weighted Avg Shares Outstanding | $201.20M | $201.10M | $199.10M | $198.90M |
| Weighted Avg Shares Outstanding (Diluted) | $201.20M | $201.10M | $200.60M | $200.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan